4.7 Review

Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy

Journal

CARDIOVASCULAR RESEARCH
Volume 85, Issue 2, Pages 347-356

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvp225

Keywords

Viral myocarditis; Dilated cardiomyopathy; Coxsackievirus; Proteasome; Immunoproteasome; Autophagy; Autophagosome; Proteasome activators

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. Heart and Stroke Foundation of British Columbia and Yukon
  3. Michael Smith Foundation for Health Research (MSFHR)

Ask authors/readers for more resources

The primary intracellular protein degradation systems, including the ubiquitin-proteasome and the lysosome pathways, have been emerging as central regulators of viral infectivity, inflammation, and viral pathogenicity. Viral myocarditis is an inflammatory disease of the myocardium caused by virus infection in the heart. The disease progression of viral myocarditis occurs in three distinct stages: acute viral infection, immune cell infiltration, and cardiac remodelling. Growing evidence suggests a crucial role for host proteolytic machineries in the regulation of the pathogenesis and progression of viral myocarditis in all three stages. Cardiotropic viruses evolve different strategies to subvert host protein degradation systems to achieve successful viral replication. In addition, these proteolytic systems play important roles in the activation of innate and adaptive immune responses during viral infection. Recent evidence also suggests a key role for the ubiquitin-proteasome and lysosome systems as the primary effectors of protein quality control in the regulation of cardiac remodelling. This review summarizes the recent advances in understanding the direct interaction between cardiotropic viruses and host proteolytic systems, with an emphasis on coxsackievirus B3, one of the primary aetiological agents causing viral myocarditis, and highlights possible roles of the host degradation systems in the pathogenesis of viral myocarditis and its progression to dilated cardiomyopathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available